Company intelligence / Profile preview

Pockit Diagnostics

Cambridge, England, United Kingdompockitdx.co.uk ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed and validated a novel point-of-care blood test (LVOne) that can identify large vessel occlusion strokes within minutes. Clinical studies indicate the device enables paramedics to recognize LVO cases rapidly and direct patients to appropriate care centers, potentially saving over an hour in treatment time compared to current pathways. The technology has been validated with novel biomarkers but full commercial launch status or pivotal trial results are not yet public.

Therapeutic areas: Neurology
Modalities: DeviceBiomarker-based diagnostic test
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

LVOne

Pre-clinical

Indications: Large vessel occlusion stroke

Partnerships

APEX Ventures Medical Fund (investment partnership)

Beyond the preview

Go deeper on Pockit Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pockit Diagnostics.

Explore the full profile